The Labetalol Hydrochloride Tablets, cataloged under National Stock Number 6505-01-218-7438, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 5 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 6 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 3 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-218-7438 |
| Primary Part Number | 00185001001 |
| Item Name | Labetalol Hydrochloride Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| 00185001001 PRIMARY | Sandoz Inc. (USA) |
| NDC60976-0346-43 | Glaxo Wellcome Inc (USA) |
| NDC00185-0010-01 PRIMARY | Sandoz Inc. (USA) |
| 00172436460 PRIMARY | Ivax Pharmaceuticals Inc. Div Division of Teva Pharmaceuticals (USA) |
| NDC00172-4364-60 PRIMARY | Ivax Pharmaceuticals Inc. Div Division of Teva Pharmaceuticals (USA) |
| Reference | Meaning |
|---|---|
| NDC00173-0346-43 | 5/9 Secondary reference Glaxo Wellcome Inc |
| NDC53489-0354-01 | 3/9 Design control — primary reference Mutual Pharmaceutical Company, Inc. Dba Url Pharma |
| NDC00085-0244-04 | 5/9 Secondary reference Schering Laboratories Institutional Sales Dept K-11-3 L-5 |
| NORMODYNE | 5/9 Secondary reference Schering Laboratories Institutional Sales Dept K-11-3 L-5 |
| TRANDATE | 5/9 Secondary reference Glaxo Wellcome Inc |
| TRANDATE TABLETS | 5/9 Secondary reference Glaxo Wellcome Inc |
NSN 6505-01-218-7438 is a Labetalol Hydrochloride Tablets, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-218-7438 has 5 manufacturer part numbers on file: 00185001001 (Sandoz Inc.), NDC60976-0346-43 (Glaxo Wellcome Inc), NDC00185-0010-01 (Sandoz Inc.), 00172436460 (Ivax Pharmaceuticals Inc. Div Division of Teva Pharmaceuticals), NDC00172-4364-60 (Ivax Pharmaceuticals Inc. Div Division of Teva Pharmaceuticals).
3 possible matches (shared part number, not a government interchangeability claim): 6505-01-237-0557, 6505-01-257-9990, 6505-01-285-0171. Verify interchangeability with system specifications before substitution.
Key specifications for 00185001001: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: LABETALOL HYDROCHLORIDE TABLETS 100MG 100S. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.